Ac immune kol webinar on the potential benefits of vaccines for alzheimer's and parkinson's diseases

Lausanne, switzerland, aug. 24, 2022 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today hosted key opinion leader (kol) cynthia a. lemere, ph.d., of the ann romney center for neurologic diseases at brigham & women's hospital and harvard medical school, boston, for a webinar focused on vaccines to treat and prevent alzheimer's and parkinson's diseases.
ACIU Ratings Summary
ACIU Quant Ranking